EUVIMEDEUVIMED entdecken
Crossref

New Drugs: Faricimab-svoa (Vabysmo ™ ) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti ™ ) for Glaucoma and Ocular Hypertension

Lana Gettman

The Senior Care Pharmacist · 2023

DOI: 10.4140/tcp.n.2023.497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Senior Care Pharmacist, 2023. Verfasst von Lana Gettman. Beteiligte Einrichtung: Harding University College of Pharmacy, Searcy, Arkansas. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Glaucoma, Ocular Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two drugs are covered in this quarterly column. Faricimab-svoa (Vabysmo ™ ) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti ™ ) for Glaucoma and Ocular Hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaDiabetic RetinopathyGlaucomaOcular HypertensionMacular DegenerationDiabetes MellitusHumansGlycinePyrazolesPyridinesAntibodies, Bispecific

Substanzen

omidenepag isopropylGlycinePyrazolesPyridinesfaricimabAntibodies, Bispecific

Autor:innen und Institutionen

  • Harding University College of Pharmacy, Searcy, Arkansas.

Zitieren

APA

Gettman, L. (2023). New Drugs: Faricimab-svoa (Vabysmo ™ ) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti ™ ) for Glaucoma and Ocular Hypertension. The Senior Care Pharmacist. https://doi.org/10.4140/tcp.n.2023.497

Vancouver

Gettman L. New Drugs: Faricimab-svoa (Vabysmo ™ ) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti ™ ) for Glaucoma and Ocular Hypertension. The Senior Care Pharmacist. 2023. doi:10.4140/tcp.n.2023.497

BibTeX
@article{Gettman2023,
  author = {Gettman, Lana},
  title = {New Drugs: Faricimab-svoa (Vabysmo ™ ) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti ™ ) for Glaucoma and Ocular Hypertension},
  journal = {The Senior Care Pharmacist},
  year = {2023},
  doi = {10.4140/tcp.n.2023.497}
}
Kostenlos starten →